Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 27 Sep 2026 · Editorial standards

At a glance

China National Center for Cardiovascular Diseases is the lead sponsor of 93 current clinical trials in our China register. 59 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Rivaroxaban, Aspirin and Berberine. The most-studied condition is Coronary Artery Disease.

ClinicalTrials.gov trials by status

Recruiting5963%
Not yet open2426%
Active, closed78%
By invitation33%

Trials by phase

Observational3841%
Not applicable3639%
Phase 41617%
Phase 211%
Phase EARLY_PHASE111%
Phase 111%

Clinical trials sponsored by China National Center for Cardiovascular Diseases

93 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI NCT05638867 · ClinicalTrials.gov ↗ · Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Drugs: Aspirin, Clopidogrel, Rivaroxaban	Phase 4	Recruiting	2023-11	China
CVI Alterations in FD: a Prospective, Multicenter, Observational Cohort Study NCT06512571 · ClinicalTrials.gov ↗ · Fabry Disease, Cardiac Variant	Observational	Recruiting	2024-12	China
Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease NCT07031531 · ClinicalTrials.gov ↗ · Premature Coronary Heart Disease	Not applicable	Recruiting	2025-08	China
Perioperative Transcutaneous Fluorescence Detection of GFR Trajectory for the Early Prediction and Diagnosis of CSA-AKI. NCT07749417 · ClinicalTrials.gov ↗ · Acute Kidney Injury	Observational	Recruiting	2026-07	China
"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients NCT06615609 · ClinicalTrials.gov ↗ · Post Coronary Artery Bypass Grafting, Hypertension, Diabetes Mellitus	Not applicable	Recruiting	2025-09	China
Perioperative Cerebral Function Assessment for Cardiac Surgery NCT06660602 · ClinicalTrials.gov ↗ · Cardiac Surgery	Observational	Recruiting	2025-02	China
Non-pharmacologial, Non-invassive Intervention Before Cardiac Surgery: a Randomized Controlled Trial NCT06791551 · ClinicalTrials.gov ↗ · Cardiac Surgery	Not applicable	Recruiting	2025-06	China
Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study NCT05372263 · ClinicalTrials.gov ↗ · Pulmonary Hypertension	Observational	Recruiting	2021-08	China
Multi-modal Adverse Events Prediction for Premature Coronary Heart Disease Trial: MAP-CHD Trial NCT07004452 · ClinicalTrials.gov ↗ · Premature Coronary Heart Disease	Observational	Recruiting	2025-03	China
Corheart 6: Long-term Cohort Study NCT07094919 · ClinicalTrials.gov ↗ · Heart Failure	Not applicable	Recruiting	2021-12	China
Calcium-Phosphorus Regulation Therapy on Heart Valve Disease NCT06660524 · ClinicalTrials.gov ↗ · Degenerative Heart Valve Disease, Heart Valve Calcification, Chronic Kidney Disease(CKD)	Phase 4	Recruiting	2024-03	China
Natural History of Coronary Atherosclerosis NCT06040073 · ClinicalTrials.gov ↗ · Coronary Artery Disease Progression, Radial Wall Strain, Atherosclerotic Lesion	Observational	Recruiting	2024-07	China
The Chinese Hypertrophic Cardiomyopathy Study(CHCS) NCT02696135 · ClinicalTrials.gov ↗ · Cardiomyopathy, Hypertrophic	Observational	Recruiting	2011-03	China
Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF) NCT07601763 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF), Atrial Fibrillation Ablation, Atrial Fibrillation Recurrent	Not applicable	Recruiting	2025-04	China
China Structural Ventricular Arrhythmias Registry NCT03821051 · ClinicalTrials.gov ↗ · Ventricular Arrythmia	Observational	Recruiting	2017-10	China
Aortic No-Touch vs Partial Aortic Clamping in Off-Pump CABG NCT07302659 · ClinicalTrials.gov ↗ · Coronary Artery Bypass Graft (CABG)	Not applicable	Recruiting	2026-03	China
Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease NCT06932874 · ClinicalTrials.gov ↗ · Atherosclerotic Heart Disease, Type 2 Diabetes Drug: Glucophage	Phase 4	Recruiting	2025-03	China
Risk Factors for Stroke or Systemic Embolism in Chinese Patients with Non-Valvular Atrial Fibrillation Registry NCT05598632 · ClinicalTrials.gov ↗ · Atrial Fibrillation, Stroke	Observational	Recruiting	2023-04	China
Efficacy of Self-expandable and Balloon-expandable Valves in Patients With Ascending Aortic Dilation NCT06743568 · ClinicalTrials.gov ↗ · Aortic Stenosis, Ascending Aortic Dilatation	Not applicable	Recruiting	2024-10	China
China Inherited Ventricular Arrhythmias Registry NCT03880708 · ClinicalTrials.gov ↗ · Ventricular Arrythmia	Observational	Recruiting	2017-10	China
A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug-coated Stents and the Xience Drug-eluting Stent System in Patients With Acute Coronary Syndrome and High Bleeding Risk Using Optical Coherence Tomography NCT07230847 · ClinicalTrials.gov ↗ · Coronary Heart Disease, Acute Coronary Syndrome	Not applicable	Recruiting	2025-12	China
Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension NCT06055452 · ClinicalTrials.gov ↗ · Pre-Heart Failure, Hypertension Drug: Dapagliflozin	Phase 4	Recruiting	2024-01	China
Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia) NCT07400549 · ClinicalTrials.gov ↗ · Hypertension, Hyperglycemia, Hyperlipidemia	Not applicable	Recruiting	2025-06	China
LDL Cholesterol TARGETs in OLDer Patients (Age≥75 Years) With ASCVD (TARGET OLD) NCT05765370 · ClinicalTrials.gov ↗ · Atherosclerotic Cardiovascular Disease, Older Patients, LDL Cholesterol	Not applicable	Recruiting	2023-03	China
Internal Microstructure of Patent Foramen Ovale Related to Stroke NCT04686253 · ClinicalTrials.gov ↗ · Patent Foramen Ovale	Observational	Recruiting	2020-12	China
National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis NCT05437965 · ClinicalTrials.gov ↗ · Coronary Artery Disease, Arteritis, In-Stent Stenosis (Restenosis) of Coronary Artery Stent	Observational	Recruiting	2020-06	China
Implementation of Machine Learning and Hemodynamic Profiles Based Clinical Decision Support Systems for Personalized Guideline Accordant Antihypertensive Regimens in Primary Care: a Pragmatic Cluster Randomized Controlled Trial NCT06828692 · ClinicalTrials.gov ↗ · Hypertension	Not applicable	Recruiting	2025-05	China
Pre-trial of Clinical Trial of Traditional Chinese Medicine Treatment for Elderly Patients With Coronary Heart Disease Who Are Still Symptomatic After Optimal Medical Treatment NCT07041359 · ClinicalTrials.gov ↗ · Coronary Arterial Disease (CAD)	Phase 4	Recruiting	2025-08	China
Effect of Mobile-Based Home Cardiac Rehabilitation on Coronary Plaque NCT07660419 · ClinicalTrials.gov ↗ · Coronary Artery Disease (CAD), Coronary Stenosis	Not applicable	Recruiting	2024-12	China
A Chinese Multicenter Study on Surgical Techniques and Outcomes Across the Lifespan in Congenital Heart Disease NCT07524998 · ClinicalTrials.gov ↗ · Congenital Heart Disease, Complex Congenital Heart Disease, Surgery (Cardiac)	Observational	Recruiting	2025-02	China
Ademetionine in Obstructive Hypertrophic Cardiomyopathy NCT07367724 · ClinicalTrials.gov ↗ · Obstructive Hypertrophic Cardiomyopathy (oHCM)	Phase 2	Recruiting	2026-01	China
Potts-shunt for the Treatment of Pediatric Patients With Severe Pulmonary Hypertension NCT06429579 · ClinicalTrials.gov ↗ · Pulmonary Artery Hypertension	Not applicable	Recruiting	2024-04	China
Clinical Performance and Quality Measures for Adults With Acute ST-Elevation Myocardial Infarction in China NCT04088682 · ClinicalTrials.gov ↗ · ST Elevation Myocardial Infarction	Observational	Recruiting	2018-07	China
Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy NCT05782270 · ClinicalTrials.gov ↗ · Anticoagulation, Coronary Endarterectomy Drugs: DAPT, Warfarin	Phase 4	Recruiting	2023-04	China
Safety and Efficacy of the Extracorporeal Ventricular Assist System in Car Diogenic Shock: A Prospective, Multicenter , Single-Arm Study NCT07769528 · ClinicalTrials.gov ↗ · Cardiogenic Shock	Not applicable	Recruiting	2026-03	China
24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial NCT06014060 · ClinicalTrials.gov ↗ · Elevated Lipoprotein(a) Level, Coronary Artery Disease, Drug-Eluting Stent	Not applicable	Recruiting	2025-06	China
AI Facial Analysis Algorithm to Screening Coronary Artery Disease in High-Risk Community Population NCT07277686 · ClinicalTrials.gov ↗ · Coronary Artery Disease (CAD), Artificial Intelligence Algorithms, Face	Observational	Recruiting	2025-12	China
LAA Clipping Versus NOACs to Prevent Stroke in Non-paroxysmal Atrial Fibrillation. NCT06021808 · ClinicalTrials.gov ↗ · Non-paroxysmal Atrial Fibrillation	Not applicable	Recruiting	2024-04	China
Goal Setting and Mobile-based Self-management Tool to Improve Diet Quality of People With High Blood Pressure NCT06988501 · ClinicalTrials.gov ↗ · Blood Pressure, High	Not applicable	Recruiting	2024-07	China
Clinical Implications of Three-vessel Ultrasonic Flow Ratio Measurement in Patients With Coronary Artery Disease NCT06822894 · ClinicalTrials.gov ↗ · Coronary Artery Disease (CAD)	Observational	Recruiting	2025-06	China
IVUS-FFR Accuracy for Coronary Stenosis NCT07446023 · ClinicalTrials.gov ↗ · Percutaneous Coronary Intervention, Intravenous Ultrasound, Coronary Physiology	Not applicable	Recruiting	2025-07	China
Unipolar Voltage Mapping for Personalized Atrial Fibrillation Ablation NCT07630857 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF)	Not applicable	Recruiting	2026-06	China
AI Model for Assessing Cardiac Surgeons' Techniques NCT06739005 · ClinicalTrials.gov ↗ · CABG-patients, CABG, Cardiovascular Surgery	Observational	Recruiting	2025-01	China
Discovery and Validation of Biomarkers for CSA-AKI Risk Prediction NCT07811570 · ClinicalTrials.gov ↗ · CSA-AKI, Acute Kidney Injury, Cardiovascular Surgery	Observational	Recruiting	2026-03	China
Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement NCT05739253 · ClinicalTrials.gov ↗ · Aortic Stenosis, Ascending Aortic Dilatation, Bicuspid Aortic Valve	Observational	Recruiting	2022-03	China
Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation NCT06108414 · ClinicalTrials.gov ↗ · Atrial Fibrillation, Anticoagulant Adverse Reaction, Stroke Drug: Rivaroxaban	Phase 4	Recruiting	2024-09	China
Effects of Left Atrial Appendage Resection and Marshall Ligament Amputation on Clinical Outcome in Patients Undergoing Off-pump Coronary Artery Bypass NCT04220047 · ClinicalTrials.gov ↗ · Coronary Artery Disease, Stroke, Atrial Fibrillation	Not applicable	Recruiting	2020-04	China
Concomitant Hybrid Versus Catheter Ablation for Atrial Fibrillation With Hypertrophic Cardiomyopathy NCT05610215 · ClinicalTrials.gov ↗ · Atrial Fibrillation, Cardiomyopathy, Hypertrophic, Radiofrequency Ablation	Not applicable	Recruiting	2023-02	China
Cerebral Microembolization Associated With PFO Closure NCT06347276 · ClinicalTrials.gov ↗ · Thrombosis Cardiac, Atrial Septal Defect, Patent Foramen Ovale (PFO)	Observational	Recruiting	2024-01	China
Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation NCT06615596 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF)	Phase EARLY_PHASE1	Recruiting	2025-08	China
Intelligent Management Platform for Guiding Exercise Rehabilitation in Coronary Heart Disease Patients NCT07259278 · ClinicalTrials.gov ↗ · Secondary Prevention of Coronary Heart Disease	Not applicable	Recruiting	2025-12	China
Intensive Treatment on Periodontitis in Aortic Stenosis NCT06587971 · ClinicalTrials.gov ↗ · Aortic Valve Stenosis, Periodontitis	Not applicable	Recruiting	2023-05	China
A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension NCT06554301 · ClinicalTrials.gov ↗ · Pulmonary Arterial Hypertension	Phase 1	Recruiting	2024-10	China
Registration Study for Rare Type of Pulmonary Hypertension NCT03169010 · ClinicalTrials.gov ↗ · Pulmonary Hypertension	Observational	Recruiting	2017-05	China
Chinese Occupational Population Cohort of Lifestyle and Physical Fitness (LiFitChina) NCT06275009 · ClinicalTrials.gov ↗ · Lifestyle, Physical Fitness, Cardiovascular Diseases	Observational	Recruiting	2023-12	China
Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease NCT06917664 · ClinicalTrials.gov ↗ · Coronary Artery Disease, Ischemic Mitral Regurgitation, Angiotensin Receptor/Neprilysin Inhibitor	Phase 4	Recruiting	2025-06	China
Modified Aortic Root Enlargement Procedure NCT06517537 · ClinicalTrials.gov ↗ · Small Aortic Annulus, Aortic Root Enlargement Procedure	Observational	Recruiting	2024-07	China
Effect of Xuesaitong Soft Capsules on Major Risk Factors in Patients With Coronary Heart Disease NCT06425120 · ClinicalTrials.gov ↗ · Coronary Heart Disease Drug: Xuesaitong soft	Phase 4	Recruiting	2024-06	China
QFR-Guided Virtual Stenting for Preprocedural Physiological Optimization of Percutaneous Coronary Intervention: A Randomized Controlled Trial NCT07635407 · ClinicalTrials.gov ↗ · Coronary Artery Disease, Coronary Stenosis, Ischemic Heart Disease	Not applicable	Recruiting	2026-06	China
A Prospective Multicenter Real-World Registry of Quantitative Flow Ratio-Guided Coronary REvascularization and QuAlity evaLuation NCT07766434 · Coronary Artery Disease	Observational	Not yet open	2026-08	China
Sirolimus-Coated vs Paclitaxel-Coated DCBs in ACS Treatment NCT07514988 · ClinicalTrials.gov ↗ · Acute Coronary Syndromes (ACS)	Not applicable	Not yet open	2026-05	China
rhBNP for Prevention of Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) NCT07617675 · ClinicalTrials.gov ↗ · AKI - Acute Kidney Injury, Cardiac Surgical Procedures, Cardiopulmonary Bypass	Phase 4	Not yet open	2026-05	China
Precise Phenotyping Classification in Atrial Fibrillation NCT07044011 · ClinicalTrials.gov ↗ · Atrial Fibrillation	Observational	Not yet open	2025-08	China
Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis（ECHO-TAVR） NCT07317804 · ClinicalTrials.gov ↗ · Aortic Stenosis, TAVI, TAVI(Transcatheter Aortic Valve Implantation)	Phase 4	Not yet open	2026-04	China
A Multicenter Randomized Controlled Trial of Echocardiography-Guided Atrial Septal Defect Closure Performed in a Mobile Surgical Unit NCT07273227 · ClinicalTrials.gov ↗ · ASD - Atrial Septal Defect	Phase 4	Not yet open	2025-12	China
pCAD-POAF 3 Year Follow-up NCT07146061 · ClinicalTrials.gov ↗ · Coronary Artery Disease, Atrial Fibrillation	Observational	Not yet open	2025-08	China
Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity NCT07657676 · ClinicalTrials.gov ↗ · Obesity & Overweight, Coronary Heart Disease Drug: Mazdutide	Phase 4	Not yet open	2026-09	China
Preventing Neurologic Complications in Valve Surgery NCT07382362 · ClinicalTrials.gov ↗ · Left Atrial Appendage Closure	Observational	Not yet open	2026-01	China
Precision Medicine Study on Cardiovascular Disease (PRECISE) NCT04434911 · ClinicalTrials.gov ↗ · Cardiovascular Diseases	Observational	Not yet open	2021-03	China
AI-Generated Video Feedback to Improve Technical Skills in Coronary Artery Bypass Grafting NCT07400172 · ClinicalTrials.gov ↗ · Cardiac, Surgery (Cardiac), Education	Not applicable	Not yet open	2026-01	China
Micro-axial Flow Pump-Supported PCI in Complex Coronary Artery Disease With Ischemic LV Dysfunction NCT07678021 · ClinicalTrials.gov ↗ · Coronary Artery Disease (CAD)	Not applicable	Not yet open	2026-08	China
The China CardioMyopathy Registry Study NCT05871632 · ClinicalTrials.gov ↗ · Cardiomyopathies	Observational	Not yet open	2023-07	China
Evaluating the Safety and Effectiveness of a Vascular Interventional Robotic System in Assisting With Percutaneous Coronary Intervention Procedures: A Prospective, Multicenter, Randomized Controlled Clinical Trial NCT07233317 · ClinicalTrials.gov ↗ · Coronary Artery Disease	Not applicable	Not yet open	2025-12	China
Skeletal Muscle Multi-omics Analysis and Risk Tailoring in Sudden Cardiac Death NCT07476456 · ClinicalTrials.gov ↗ · Sudden Cardiac Death	Observational	Not yet open	2026-03	China
Construction and Validation of a Coronary Artery Disease-Specific Large Language Model and Its Evaluation Framework (CorAI) NCT07766551 · ClinicalTrials.gov ↗ · Coronary Heart Disease (CHD), Artifical Intelligence	Observational	Not yet open	2026-08	China
Low-dose Colchicine for Thromboprophylaxis After Transcatheter Aortic Valve Replacement NCT07411768 · ClinicalTrials.gov ↗ · Transcatheter Aortic Valve Replacement, Transcatheter Heart Valve Thrombosis, Anti-inflammatory Therapy Drug: Colchicine	Not applicable	Not yet open	2026-03	China
Radial Artery Versus No-touch Saphenous Vein NCT06014047 · ClinicalTrials.gov ↗ · Coronary Artery Disease	Not applicable	Not yet open	2023-11	China
Effect of Finerenone on Myocardial Fibrosis and Cardiac Function in HFmrEF/HFpEF Patients NCT07583173 · ClinicalTrials.gov ↗ · Heart Failure Drug: Finerenone	Phase 4	Not yet open	2026-05	China
PRECISE-AFMR I: Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk NCT07741253 · ClinicalTrials.gov ↗ · Atrial Functional, Mitral Regurgitation (MR)	Not applicable	Not yet open	2026-08	China
Predicting Post-Cardiac Surgery Acute Kidney Disease: A Machine Learning Approach NCT07482683 · ClinicalTrials.gov ↗ · Acute Kidney Disease	Observational	Not yet open	2026-03	China
IVUS-Guided Sirolimus-Coated Balloon Versus Sirolimus-Eluting Stent for De Novo Large Vessel Lesions in ACS NCT07796412 · ClinicalTrials.gov ↗ · Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)	Not applicable	Not yet open	2026-09	China
Vasopressor Agents in Pulmonary Hypertension Crisis NCT07667829 · ClinicalTrials.gov ↗ · Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Pulmonary Hypertension (CTEPH), Hypertension, Pulmonary Drugs: Dopamine, Epinephrine, Norepinephrine	Not applicable	Not yet open	2026-06	China
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT NCT07762755 · ClinicalTrials.gov ↗ · Coronary Artery Disease, Hyperlipidaemia, Hypertriglyceridaemia Drug: Icosapent Ethyl	Phase 4	Not yet open	2026-08	China
A Clinical Study on the Use of the Sentinel Cerebral Protection Device During TAVR for the Prevention of Procedure-Related Stroke NCT07045233 · ClinicalTrials.gov ↗ · Stroke, Transcatheter Aortic Valve Replacement (TAVR), Aortic Stenosis Treated With TAVI	Observational	By invitation	2025-06	China
Healthy Adult Reference Biobank for Cardiovascular Biomarkers in China NCT07136675 · ClinicalTrials.gov ↗ · Healthy Individuals (Controls)	Observational	By invitation	2025-04	China
Comparison of 6F and 7F Sheaths for Coronary Intervention Via Distal Radial Artery Access NCT06585917 · ClinicalTrials.gov ↗ · PCI, Coronary Arterial Disease (CAD)	Not applicable	By invitation	2024-09	China
No-Touch Versus Conventional Saphenous Vein Harvesting Technique NCT03126409 · Coronary Artery Disease	Not applicable	Active, closed	2017-05	China
An Observational Study of Subcutaneous Implantable Cardioverter Defibrillator in Patients with Hypertrophic Cardiomyopathy At High Risk of Sudden Cardiac Death NCT06604169 · ClinicalTrials.gov ↗ · HCM - Hypertrophic Cardiomyopathy, S-ICD System (implantable Defibrillator)	Observational	Active, closed	2024-08	China
Postoperative Infections and Immune Profiles in Patients Undergoing LVAD Implantation NCT07255716 · ClinicalTrials.gov ↗ · Infection, Driveline Heart-assisted Device Related Infection, Pneumonia	Observational	Active, closed	2020-06	China
STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial NCT06084000 · ClinicalTrials.gov ↗ · Drug-coated Balloon, Drug-eluting Stent, De Novo Stenosis	Not applicable	Active, closed	2023-10	China
Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus NCT05749874 · ClinicalTrials.gov ↗ · PreDiabetes, Abdominal Obesity, Hypertension Drug: Berberine	Phase 4	Active, closed	2023-10	China
SMCs With LVH Compared to HCM NCT07006974 · ClinicalTrials.gov ↗ · Syndromic and Metabolic Cardiomyopathy, Cardiomyopathies	Observational	Active, closed	2025-05	China
Artificial Intelligence-assisted Diagnosis NCT06783933 · ClinicalTrials.gov ↗ · Congenital Heart Disease (CHD), Structural Heart Disease	Observational	Active, closed	2025-01	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in China National Center for Cardiovascular Diseases trials

16 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Rivaroxaban2 Aspirin1 Berberine1 Clopidogrel1 Colchicine1 DAPT1 Dapagliflozin1 Dopamine1 Epinephrine1 Finerenone1 Glucophage1 Icosapent Ethyl1 Mazdutide1 Norepinephrine1 Warfarin1 Xuesaitong soft1

Conditions in China National Center for Cardiovascular Diseases trials

140 conditions

Coronary Artery Disease12 Atrial Fibrillation6 Hypertension5 Stroke4 Coronary Artery Disease (CAD)4 Aortic Stenosis3 Atrial Fibrillation (AF)3 Coronary Heart Disease3 Percutaneous Coronary Intervention2 Acute Coronary Syndrome2Premature Coronary Heart Disease2Acute Kidney Injury2 Hyperlipidemia2 Cardiac Surgery2 Pulmonary Hypertension2 Heart Failure2Cardiomyopathy, Hypertrophic2Ventricular Arrythmia2Ascending Aortic Dilatation2Cardiovascular Diseases2Surgery (Cardiac)2Coronary Arterial Disease (CAD)2Coronary Stenosis2Cardiomyopathies2

By trial register

Register	Trials	Recruiting
Clinical trials in China	93	59

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Coronary Artery Disease

Sponsor	Trials
Seung-Jung Park	14
Fundación EPIC	14
Samsung Medical Center	12
Yonsei University	11
Nanjing First Hospital, Nanjing Medical University	10
Second Affiliated Hospital, Zhejiang University, School of Medicine	8
Shanghai Zhongshan Hospital	7
Ottawa Heart Institute Research Corporation	6
Xijing Hospital	6
Rigshospitalet, Denmark	5

Sponsors with the most current trials registered for this condition.

Questions about China National Center for Cardiovascular Diseases trials

How many clinical trials does China National Center for Cardiovascular Diseases sponsor?

China National Center for Cardiovascular Diseases is the lead sponsor of 93 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 27 September 2026. Completed and withdrawn studies are not counted.

Are China National Center for Cardiovascular Diseases trials recruiting?

Yes. 59 of its 93 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is China National Center for Cardiovascular Diseases testing?

Its current trials name 16 drugs and biologicals as interventions. The most frequent are Rivaroxaban (2), Aspirin (1), Berberine (1), Clopidogrel (1) and Colchicine (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 27 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

China National Center for Cardiovascular Diseases clinical trials